PFW Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
26,295
+313
| +1% | +$5.25K | 0.14% | 90 |
|
|
2025
Q1 | $399K | Sell |
25,982
-8
| -0% | -$123 | 0.13% | 91 |
|
|
2024
Q4 | $573K | Buy |
+25,990
| New | +$573K | 0.18% | 82 |
|
|
2024
Q2 | $422K | Buy |
25,982
+543
| +2% | +$8.82K | 0.13% | 90 |
|
|
2024
Q1 | $359K | Buy |
25,439
+121
| +0.5% | +$1.71K | 0.11% | 96 |
|
|
2023
Q4 | $264K | Buy |
25,318
+318
| +1% | +$3.32K | 0.08% | 105 |
|
|
2023
Q3 | $255K | Hold |
25,000
| – | – | 0.09% | 103 |
|
|
2023
Q2 | $245K | Buy |
+25,000
| New | +$245K | 0.08% | 109 |
|
|
2019
Q3 | $468K | Buy |
+25,982
| New | +$468K | 0.14% | 90 |
|